BRILLIANCE BIOMEDICINE CO., LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Development of 3D-printed medical devices for joint repair, as well as design and prototyping services for various types of 3D-printed medical devices. Our flagship product is a novel injectable composite artificial bone for spinal applications. It retains the advantages of bone cement injection while overcoming its drawbacks, serving as an alternative to traditional acrylic bone cement. By completely eliminating the high risks and severe complications associated with traditional acrylic bone cement, it rapidly and safely alleviates patient pain. This provides physicians and patients with a safer, more effective treatment option, establishing itself as the next-generation medical device for vertebral compression fracture surgeries.
The content above was translated by Ai
Founded Year
2016
Unified Business No.
69554862
Status
Active
Number of Employees
0
Total Paid-in
Capital
3,550,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our company's R&D team originated from Chung Yuan Christian University, primarily developing 3D-printed medical device products for joint repair, as well as design and trial manufacturing services for various types of 3D-printed medical devices. This project gathers the university's R&D capabilities and collaborates with domestic material manufacturers to independently manufacture repair scaffolds. This holds significant landmark significance for the domestic medical device industry, helps improve the medical quality of osteoarthritis treatment, and is expected to contribute to the treatment of the increasingly growing osteoarthritis disease in an aging society, as well as to the enhancement of patients' quality of life.
The content above was translated by Ai
